ido1 inhibitor 1-mt (Incyte corporation)
Structured Review

Ido1 Inhibitor 1 Mt, supplied by Incyte corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ido1+inhibitor+1-mt/pmc06799842-207-16-19?v=Incyte+corporation
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis"
Article Title: The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis
Journal: Signal Transduction and Targeted Therapy
doi: 10.1038/s41392-019-0058-5
Figure Legend Snippet: IDO1 and TDO were expressed in atherosclerotic lesions and codistributed with CD3-positive lymphocytes and CD68-positive macrophages in patients with advanced atherosclerosis. a Pathological changes of the coronary artery were revealed by HE staining (×400). b , c IDO1, TDO and the lymphocyte marker CD3 were detected in atherosclerotic lesions by immunostaining analysis (×400). d , e IDO1, TDO and the monocyte marker CD68 were detected in atherosclerotic lesions by immunostaining analysis (×400). The top panel in b – e exhibits an enlarged view of the representative region in the bottom panel
Techniques Used: Staining, Marker, Immunostaining
Figure Legend Snippet: The expression and activity of IDO1 and TDO in atherosclerotic blood samples. Serum concentrations of tryptophan ( a ) and kynurenine ( b ) and the kynurenine to tryptophan ratio Kyn/Trp ( c ) in blood samples of atherosclerotic patients with different histological classification grades ((−): n = 10, I: n = 16, II: n = 18, III: n = 7). d , e IDO1 and TDO protein levels were determined by western blot assays. f Associations between the expression of IDO1 and TDO and the concentration of Trp ( r = −0.44028, * p < 0.05; r = −0.45339, * p < 0.05). g IDO1 and TDO mRNA expression was determined by real-time PCR ((−): n = 6, I/II: n = 12, III: n = 4). Data were based on at least three independent experiments. * p < 0.05
Techniques Used: Expressing, Activity Assay, Western Blot, Concentration Assay, Real-time Polymerase Chain Reaction
Figure Legend Snippet: oxLDL induced IDO1 expression via the PI3K/Akt/NF-κB pathway in THP-M. a oxLDL induced the production of inflammatory factors. The mRNA levels of IL-10, MCP-1, IL-1β and IL-8 were measured by real-time PCR. b THP-M were challenged with 25 mg/L oxLDL for 12, 24, and 48 h, and IDO1 expression was detected by western blot analysis. c THP-M were treated with oxLDL for 24 h at 0, 25, 50 and 100 mg/L, and IDO1 expression was detected by western blot analysis. d The expression of PI3K/Akt/NF-κB pathway-related proteins in THP-M was detected by western blot analysis. THP-M were treated with oxLDL (25 mg/L) for 24 h. e The expression levels of pAkt, pp65, IDO1 and β-actin were detected by western blots. THP-M were pretreated with the Akt inhibitor LY294002 (5 μM) for 24 h and then treated with oxLDL (25 mg/L) for 24 h. Data were based on at least three independent experiments. * p < 0.05. f The expression levels of pp65, IDO1 and β-actin were detected by western blots. THP-M were pretreated with the NF-κB inhibitor CAPE (50 μM) for 24 h and then treated with oxLDL (25 mg/L) for 24 h
Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Western Blot
Figure Legend Snippet: Before and after oxLDL treatment, the promoting effects of IFN-γ on IDO1 expression and the degree of foaming of THP-M. a Induction of IDO1 by different treatments was detected by immunofluorescence (×200). b The degree of foaming was detected by Oil red O staining (×400). c Quantitative analysis of Oil red O intensity (Oil red O staining area/cell area and Oil red O staining particles per cell). The designation of different treatments, such as oxLDL, IFN-γ, IFN-γ+ oxLDL and oxLDL+IFN-γ, was described in the Materials and Methods. Data were based on at least three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001
Techniques Used: Expressing, Foaming, Immunofluorescence, Staining
Figure Legend Snippet: Before and after oxLDL treatment, the IFN-γ-mediated promotion of THP-M foaming was reversed by IDO1 inhibition. a , b IDO1 activity (Kyn/Trp) was detected by HPLC. c , d The results of Oil red O staining (×400). The designation of different treatments, such as oxLDL, IFN-γ, IFN-γ+oxLDL, oxLDL+IFN-γ, IFN-γ+Incyte+oxLDL, oxLDL+IFN-γ+Incyte, IFN-γ+1-MT+oxLDL and oxLDL+IFN-γ+1-MT, was described in the Materials and Methods. Data were based on at least three independent experiments. * p < 0.05
Techniques Used: Foaming, Inhibition, Activity Assay, Staining
Figure Legend Snippet: Before and after oxLDL treatment, IFN-γ-induced IDO1 exhibited different degrees of promotion on cell apoptosis and inflammatory factor production. a The degree of cell apoptosis was evaluated by flow cytometry. PI for nuclear staining and Annexin V-FITC for cytomembrane staining. The UL (upper left) quadrant represents cellular debris and damaged cells. The UR (upper right) and LR (lower right) quadrants represent apoptotic cells in the late or early stages. The LL (lower left) quadrant shows the normal cells. b Quantitative analysis of cell apoptosis. The total cell apoptosis is the sum of the percentage of late cell and early cell apoptosis. c Western blot analysis of caspase-3 expression in THP-M. d The mRNA levels of IL-10, MCP-1, IL-1β and IL-8 were measured by real-time PCR. Data were based on at least three independent experiments. * p < 0.05, ** p < 0.01
Techniques Used: Flow Cytometry, Staining, Western Blot, Expressing, Real-time Polymerase Chain Reaction
Figure Legend Snippet: Before and after oxLDL treatment, the IFN-γ-mediated promotion of cell apoptosis and inflammatory factor production were reversed by IDO1 inhibition. a Western blot analysis of caspase-3 expression in THP-M. b The mRNA levels of IL-10, MCP-1, IL-1β and IL-8 were measured by real-time PCR. The designation of different treatments, such as IFN-γ+oxLDL, oxLDL+IFN-γ, IFN-γ+Incyte+oxLDL, oxLDL+IFN-γ+Incyte, IFN-γ+1-MT+oxLDL and oxLDL+IFN-γ+1-MT, was described in the Materials and Methods. Data were based on at least three independent experiments. * p < 0.05, ** p < 0.01
Techniques Used: Inhibition, Western Blot, Expressing, Real-time Polymerase Chain Reaction
Figure Legend Snippet: The IDO1 inhibitor 1-MT could ameliorate the development of atherogenesis in high-fat diet (HFD)-fed ApoE −/− mice. Eight-week-old WT and ApoE −/− mice were used and killed at 12 weeks of age. a Representative photomicrographs of aortic roots from 12-week-old mice of different groups stained with Oil red O. b The atherosclerotic plaque area/total aortic sinus area ratio. Atherosclerotic lesion areas were measured as the mean sizes of multiple plaques located in 5 sections in each mouse. c IDO1 activity analyzed by HPLC (WT group: n = 6, CMC group: n = 4, 1-MT group: n = 4). d Total cholesterol (TC). e High-density lipoprotein cholesterol (HDL-C). f Low-density lipoprotein cholesterol (LDL-C). n = 4. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Techniques Used: Staining, Activity Assay
Figure Legend Snippet: Primers used for real-time PCR
Techniques Used:
